Holders over time
- NTRA
- TMO
| Quarter | NTRA | TMO |
|---|---|---|
| Q4 2020 | 15 holders, $741m | 33 holders, $39.2bn |
| Q1 2021 | 17 holders, $911m | 35 holders, $36.5bn |
| Q2 2021 | 20 holders, $1.4bn | 33 holders, $38.3bn |
| Q3 2021 | 17 holders, $1.3bn | 32 holders, $42.6bn |
| Q4 2021 | 14 holders, $1.2bn | 38 holders, $50.1bn |
| Q1 2022 | 13 holders, $551m | 32 holders, $43.2bn |
| Q2 2022 | 14 holders, $473m | 33 holders, $38.9bn |
| Q3 2022 | 10 holders, $365m | 26 holders, $34.3bn |
| Q4 2022 | 12 holders, $266m | 29 holders, $37.0bn |
| Q1 2023 | 14 holders, $658m | 35 holders, $37.1bn |
| Q2 2023 | 10 holders, $474m | 39 holders, $33.5bn |
| Q3 2023 | 10 holders, $554m | 39 holders, $32.6bn |
| Q4 2023 | 12 holders, $695m | 41 holders, $32.7bn |
| Q1 2024 | 18 holders, $2.0bn | 30 holders, $34.1bn |
| Q2 2024 | 22 holders, $2.5bn | 38 holders, $30.6bn |
| Q3 2024 | 25 holders, $3.6bn | 30 holders, $33.8bn |
| Q4 2024 | 28 holders, $4.5bn | 36 holders, $27.6bn |
| Q1 2025 | 21 holders, $4.6bn | 31 holders, $24.2bn |
| Q2 2025 | 21 holders, $5.4bn | 39 holders, $18.8bn |
| Q3 2025 | 23 holders, $4.8bn | 32 holders, $21.9bn |
| Q4 2025 | 26 holders, $8.1bn | 32 holders, $29.9bn |
| Q1 2026 | 20 holders, $6.7bn | 34 holders, $24.4bn |
| Q2 2026 | 23 holders, $10.0bn | 36 holders, $26.4bn |
| Q3 2026 | 22 holders, $16.9bn | 35 holders, $40.3bn |
Natera Inc
- Holders
- 22
- Reported value
- $16.9bn
- Buyers
- 16
- Sellers
- 21
Breadth -5 among 89 comparable managers.
Thermo Fisher Scientific Inc
- Holders
- 35
- Reported value
- $40.3bn
- Buyers
- 20
- Sellers
- 30
Breadth -10 among 89 comparable managers.
Who holds both, Q3 2026
Both (17)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital World Investors, D. E. Shaw & Co., Farallon Capital Management LLC, Fidelity (FMR LLC), Invesco Ltd, Man Group PLC, Maverick Capital Ltd, MFS Investment Management, Neuberger Berman Group LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP, Winton Group Ltd
Only NTRA (5)
ARK Investment Management LLC, Coatue Management LLC, Discovery Capital Management LLC, Rokos Capital Management LLP, Tudor Investment Corp
Only TMO (18)
Baillie Gifford & Co, Balyasny Asset Management LLC, Capital Research Global Investors, Caxton Associates LLP, D1 Capital Partners LP, Dodge & Cox, Egerton Capital UK LLP, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Holocene Advisors LP, Lone Pine Capital LLC, Markel Group Inc, Point72 Asset Management LP, Verition Fund Management LLC, Viking Global Investors LP, Walleye Capital LLC, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.